Roivant Sciences Ltd.

ROIV Healthcare
$21.9 $-0.2 (-0.90%)
Market Cap: $15.23 B
Gurus Holding
5
Popularity Rank
#1777
% of Shares Held
4.15%
Net Activity (Q3 2025)
-$196.04 M

Guru Ownership Over Time

Guru Analysis for Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ltd. (ROIV), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $632.46 M.

Top institutional holders include Andreas Halvorsen and Steven Cohen.

Institutional sentiment is currently Bearish. This is evidenced by a $196.04 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who increased their stake by 744.2%. Conversely, David Einhorn reduced exposure by 50.0%.

Portfolio Manager % of portfolio Activity Shares Value Peroid
0.93% Reduce -31.1% 23,594,831 $356.99 M Q3 2025
0.07% Reduce -11.6% 2,608,294 $39.46 M Q3 2025
1.35% Reduce -50.0% 2,275,529 $34.43 M Q3 2025
0.02% Add 744.2% 330,475 $5 M Q3 2025
0.00% New Buy 70,371 $1.06 M Q3 2025

Key Holders

Top 5 by Value

$356.99 M
$39.46 M
$34.43 M
$1.06 M

Top 5 by Conviction

Recent Activity Breakdown(Q3 2025)

+$5.47 M
Total Buy Value
New Buys: 1
Additions: 1
-$201.5 M
Total Sell Value
Reductions: 3
Sold Out: 1

Guru Consensus (Q3 2025)

Based on recent guru activity
Net Sellers
4
Net Buyers
2

FAQs for Roivant Sciences Ltd. (ROIV)

Top Guru holders include Andreas Halvorsen ($356.99 M), Steven Cohen ($39.46 M), David Einhorn ($34.43 M). Collectively, tracked Gurus hold 28.88 M shares.

Based on recent 13F filings, the sentiment is **Negative (Net Sell)**. There was a net outflow of $196.04 M, with 2 Gurus buying and 4 Gurus selling.

In the recent quarter, 3 Gurus reduced their positions, and 1 Gurus sold out of ROIV completely. Total sell value was $201.5 M.

Yes, 1 Gurus opened new positions in ROIV, and 1 added to their existing holdings. Total buy value was $5.47 M.